Windahl S H, Hollberg K, Vidal O, Gustafsson J A, Ohlsson C, Andersson G
Department of Biosciences, Karolinska Institutet, Novum, Huddinge, Sweden.
J Bone Miner Res. 2001 Aug;16(8):1388-98. doi: 10.1359/jbmr.2001.16.8.1388.
Recently, it has been shown that inactivation of estrogen receptor beta (ER-beta) by gene targeting results in increased cortical bone formation in adolescent female mice. To study the possible involvement of ER-beta in the regulation of the mature skeleton, we have extended the analyses to include 1-year-old ER-beta knockout mice (ER-beta-/-). Male ER-beta-/- mice did not express any significant bone phenotypic alterations at this developmental stage. However, the increase in cortical bone parameters seen already in the adolescent female ER-beta-/- mice was maintained in the older females. The aged female ER-beta-/- mice further exhibited a significantly higher trabecular bone mineral density (BMD) as well as increased bone volume/total volume (BV/TV) compared with wild-type (wt) mice. This was caused by a less pronounced loss of trabecular bone during adulthood in female ER-beta-/- mice. The growth plate width was unaltered in the female ER-beta-/- mice. Judged by the expression of the osteoclast marker tartrate-resistant acid phosphatase (TRAP) and cathepsin K (cat K; reverse-transcription-polymerase chain reaction [RT-PCR]) as well as the serum levels of C-terminal type I collagen cross-linked peptide, bone resorption appeared unaffected. However, an increase in the messenger RNA (mRNA) expression levels of the osteoblast marker core-binding factor alpha1 (Cbfa1) suggested an anabolic effect in bones of old female ER-beta-/- mice. In addition, the mRNA expression of ER-alpha was augmented, indicating a role for ER-alpha in the development of this phenotype. Taken together, the results show that ER-beta is involved in the regulation of trabecular bone during adulthood in female mice and suggest that ER-beta acts in a repressive manner, possibly by counteracting the stimulatory action of ER-alpha on bone formation.
最近的研究表明,通过基因靶向使雌激素受体β(ER-β)失活会导致青春期雌性小鼠的皮质骨形成增加。为了研究ER-β可能参与成熟骨骼的调节作用,我们将分析范围扩大到1岁的ER-β基因敲除小鼠(ER-β-/-)。在这个发育阶段,雄性ER-β-/-小鼠未表现出任何明显的骨表型改变。然而,青春期雌性ER-β-/-小鼠中已出现的皮质骨参数增加在年龄较大的雌性小鼠中得以维持。与野生型(wt)小鼠相比,老年雌性ER-β-/-小鼠的小梁骨矿物质密度(BMD)显著更高,骨体积/总体积(BV/TV)也增加。这是由于雌性ER-β-/-小鼠成年期小梁骨丢失不太明显所致。雌性ER-β-/-小鼠的生长板宽度未改变。通过破骨细胞标志物抗酒石酸酸性磷酸酶(TRAP)和组织蛋白酶K(cat K;逆转录聚合酶链反应[RT-PCR])的表达以及血清I型胶原C端交联肽水平判断,骨吸收似乎未受影响。然而,成骨细胞标志物核心结合因子α1(Cbfa1)的信使核糖核酸(mRNA)表达水平增加,提示老年雌性ER-β-/-小鼠骨骼存在合成代谢作用。此外,ER-α的mRNA表达增加,表明ER-α在该表型的发展中起作用。综上所述,结果表明ER-β参与雌性小鼠成年期小梁骨的调节,提示ER-β可能以抑制方式发挥作用,可能是通过抵消ER-α对骨形成的刺激作用。